Virbac SA (VIRP) - Financial and Strategic SWOT Analysis Review

Date: March 3, 2015
Pages: 36
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: V260CA1A86FEN
Leaflet:

Download PDF Leaflet

Virbac SA (VIRP) - Financial and Strategic SWOT Analysis Review
Virbac SA (VIRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Virbac S.A. (Virbac) is a pharmaceutical company. It specializes in the development and production of vaccines and medicines for domestic animals and livestock. The company’s drugs are formulated to prevent and cure certain animal diseases. It manufactures pet medications such as vaccines, antibiotics, pest control drugs, mouth/dental care products, ophthalmologic, anesthetics, anti-inflammatory drugs and dermatological products intended for horses, birds, dogs, cats, and rodents, and livestock medications including pest control drugs and antibiotics intended for sheep, pigs, cattle and poultry. Virbac’s product portfolio includes Browse Plus, a nutritional support for food producing animals; Epi-Otic, ear cleanser for dogs and cats; Ostovet, a food supplement to cattle; Fortius, an injectable antibiotic for the treatment of respiratory diseases in food producing animals; Pulmodox, an antibiotic for the treatment of respiratory diseases in pigs and poultry; Iverhart, chewable tablets for the prevention of canine heartworm disease and treatment of roundworms and Hookworms; Rabigen SAG2, an oral rabies vaccine; and Vetflurane, a general anaesthetic, among others. It has research and development centers, manufacturing facilitates, and subsidiaries in Europe, North America, Asia, Pacific, Latin America, and Africa and Middle East regions. Virbac is headquartered in Carros Cedex, France.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Virbac SA - Key Facts
Virbac SA - Key Employees
Virbac SA - Key Employee Biographies
Virbac SA - Major Products and Services
Virbac SA - History
Virbac SA - Company Statement
Virbac SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Virbac SA - Business Description
Virbac SA - Corporate Strategy
Virbac SA - SWOT Analysis
SWOT Analysis - Overview
Virbac SA - Strengths
Strength - Products and Services Portfolio
Strength - Geographic Presence
Strength - Research and Development Activities
Virbac SA - Weaknesses
Weakness - Substantial Debt
Virbac SA - Opportunities
Opportunity - Product Launches
Opportunity - Strategic Initiatives
Opportunity - Veterinary Market
Virbac SA - Threats
Threat - Foreign Currency Exchange Rate Risk
Threat - Highly Competitive Market
Threat - Uncertain R&D Outcomes
Virbac SA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Virbac SA, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Virbac SA, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Virbac SA, Recent Deals Summary

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Virbac SA, Key Facts
Virbac SA, Key Employees
Virbac SA, Key Employee Biographies
Virbac SA, Major Products and Services
Virbac SA, History
Virbac SA, Subsidiaries
Virbac SA, Key Competitors
Virbac SA, Ratios based on current share price
Virbac SA, Annual Ratios
Virbac SA, Interim Ratios
Virbac SA, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Virbac SA, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Virbac SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Virbac SA, Performance Chart (2009 - 2013)
Virbac SA, Ratio Charts
Virbac SA, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Virbac SA, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Virbac SA (VIRP) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: